News
23andMe sale reveals what your genetic data is worth. It’s less than you think
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK made a $300 million dollar deal with 23andMe which allowed it to acquire the genetic data of 5 million people. That means the value of each customer’s data was about $60 at that time.
Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.
Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...
23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file ...
April 22 (Reuters) - Bankrupt genetic test company 23andMe may face opposition from the U.S. government if it tries to sell itself to a foreign buyer, according to a Tuesday court filing by ...
Some important news for millions of 23andMe customers: The genetic testing company notified customers on Sunday that they now have until July 14 to file potential claims as the company navigates ...
Bankrupt DNA testing firm 23andMe agreed to support a court-approved data privacy ombudsman who would review the sale of customer’s genetic data as part of the company’s bankruptcy. The ...
(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback